Although the erythropoietic effect of cobalt has been amply demonstrated in experimental animals (1-3), in normal human beings (4, 5) , and in certain types of anemia (4, 6-8), the mechanism of this increased blood formation has not been elucidated. No evidence has been adduced that administration of cobalt causes a decrease in oxygen capacity (9) or alters the oxygen dissociation curve (10, 11) in the blood either of experimental animals or of human beings. It has been suggested, therefore, that cobalt interferes with the cellular oxidative processes of the marrow, or of some other hypothetical regulatory center for erythropoiesis, thus producing a histotoxic anoxia (4), leading in turn to increased erythropoietic activity.
Although the erythropoietic effect of cobalt has been amply demonstrated in experimental animals (1) (2) (3) , in normal human beings (4, 5) , and in certain types of anemia (4, (6) (7) (8) , the mechanism of this increased blood formation has not been elucidated. No evidence has been adduced that administration of cobalt causes a decrease in oxygen capacity (9) or alters the oxygen dissociation curve (10, 11) in the blood either of experimental animals or of human beings. It has been suggested, therefore, that cobalt interferes with the cellular oxidative processes of the marrow, or of some other hypothetical regulatory center for erythropoiesis, thus producing a histotoxic anoxia (4), leading in turn to increased erythropoietic activity.
Some support for this hypothesis is offered by observations which show that cobalt induces the formation of reversible complexes of oxygen with histidine or cysteine (12, 13) . Moreover, Barron and Barron (14) have shown that the addition of cobalt in vitro diminishes the oxygen consumption of suspensions of red cells derived from rabbits made polycythemic by the previous administration of cobalt. These authors and Davis (15) have also demonstrated that the development of cobalt-induced polycythemia is prevented by the simultaneous administration of ascorbic acid, a reducing agent known to be effective in directly reducing methemoglobin to hemoglobin (16) . It seems possible, then, that cobalt may exert its histotoxic effect by blocking the enzymatic reducing systems of cells, thus interfering with the utilization of oxygen by the cells. 1 This study was supported in part by grants from the American Cancer Society, Inc. and the Damon Runyan Memorial Fund for Cancer Research. 2Formerly, Damon Runyan Senior Fellow. 3 Formerly, Fellow, American Cancer Society, Inc.
In normal intact erythrocytes in 'itro methemoglobin is reconverted to hemoglobin spontaneously at the rate of 1.2 gm. per 100 cc. of blood per hour (17) by an enzymatic reducing system within the cells involving glucose and glycolysis (18) (19) (20) (21) . Consequently, it was considered appropriate to examine the action of cobalt in relation to the formation of methemoglobin in intact erythrocytes and to determine whether any methemoglobin thus formed was a result of direct oxidation of hemoglobin by cobalt or of an inactivation of the normal methemoglobin reducing mechanism.
METHODS
Quantitative estimation of the methemoglobin in blood was performed by the method of Evelyn and Malloy (22) Table I and demonstrate' that an appreciable amount of methemoglobin was formed in the cells incubated with cobalt. The identity of the pig- Action of Cobalt Coutreted with p-Aominophenol in the Formation of Methemoglobin in Erythrocytes The following experiments were designed to determine whether the formation of methemoglobin induced by cobaltous chloride in normal blood results from increased oxidation of hemoglobin or from inhibition of the normal reduction mechanism. The action of cobaltous chloride was, therefore, compared to that of p-aminophenol, an agent known to produce methemoglobin by accelerated oxidation of hemoglobin (25) .
The rate of formwtion of methemoglobin Teh ml. of normal defibrinated blood were mixed with 0.5 ml. of 4 gm. per cent CoCla solution. A 5 ml. sample of the same blood was mixed with 5 ml. of freshly prepared 50 mg. per cent solution of p-aminophenol. An additional 5 ml.. sample was mixed with 5 ml. of 0.85 gm. per cent NaCi. From each sample 13 aliquots of about 0.5 ml. were placed in separate 10 X 100 mm. test tubes, which were then placed in a water bath at 370 C. A methemoglobin,determination was made from one of the 0.5 ml. aliquots of the three types of mixture every two hours for 24 hours.
The results of an experiment typical of the two performed are shown in Figure 1 and indicate striking differences in the rates of formation of methemoglobin. The formation of methemoglobin induced by p-aminophenol was rapid for the first few hours and then proceeded relatively slowly. No significanit amount of methemoglobin was formed in the blood incubated with cobaltous chloride for the first 10 hours. Thereafter, methemoglobin formation gradually increased so that at the end of 24 hours 8 per cent of the hemoglobin had been oxidized to methemoglobin. In the sample, incubated with NaCl, no methemoglobin was formed at the end of 24 hours.
The effect of anoxia on methemoglobin formation It has been shown that in'the presence of oxygen, p-aminophenol will directly oxidize the hemo- The results presented in Table II indicate that in the presence of oxygen, p-aminophenol and methylene blue readily formed methemoglobin; whereas, in the absence of oxygen, they formed relatively little methemoglobin. In contrast, cobalt permitted the formation of substantially more methemoglobin in the absence of oxygen than in the oxygenated sample. The control samples incubated with sodium chloride solution showed no significant amount of methemoglobin in either gas mixture. The effect of methylene blue on the formation of methemoglobin by cobalt and by p-aminophenol It has been demonstrated that methylene blue reduces preformed methemoglobin in intact erythrocytes by accelerating the normal reconversion mechanism (27, 28) . Since the preceding experiments suggested that cobalt induces methemoglobin formation by inhibiting the normal reconversion mechanism, whereas p-aminophenol directly oxidizes hemoglobin to methemoglobin, the effects of cobalt and of p-aminophenol in the presence of appropriate amounts of methylene blue were contrasted.
To 10 ml. of normal human defibrinated blood were added 5 ml. of 50 mg. per cent p-aminophenol in 0.85 gm. per cent NaCl. To another 10 ml. sample, 0.5 ml. of 4 gm. per cent CoCl2 was added. Each sample was then divided into two equal parts. To one part of each sample, 0.5 ml. of 0.85 gm. per cent NaCl containing 0.01 gm. per cent methylene blue was added; to the other, 0.5 ml. of 0.85 gm. per cent NaCl. The samples were then incubated at 370 C., and methemoglobin determinations were done on the samples containing p-aminophenol after 8 and after 24 hours and on those samples containing cobalt after 24 hours.
The results obtained at 24 hours presented in Table III indicate that the addition of methylene blue substantially prevented methemoglobin formation in the blood containing p-aminophenol. In contrast, methylene blue did not suppress methemoglobin formation in the blood containing cobalt. The effect of ascorbic acid on the formation of methemoglobin by cobalt and by p-aminophenol
In contrast to methylene blue, ascorbic acid has been shown to reduce methemoglobin directly rather than by way of the normal cellular enzymatic process (29) . The following experiment was designed to determine whether ascorbic acid would prevent or inhibit methemoglobin formation induced by either cobalt or p-aminophenol.
To 10 ml. of normal human defibrinated blood 5 ml. of 50 mg. per cent p-aminophenol in 0.85 gm. per cent NaCl were added. To another 10 ml. of blood 0.5 ml. of 4 gm. per cent cobaltous chloride was added. Each sample was then divided into two parts. To one part was added 0.8 ml. of 2.5 gm. per cent solution of ascorbic acid; to the other was added 0.8 ml. of 0.85 gm. per cent NaCl. Another 5 ml. aliquot of blood was mixed with 0.8 ml. of 0.85 gm. per cent. NaCl to serve as a control. All samples were incubated at 370 C. Methemoglobin determinations were done on all samples at the end of 8 hours and of 24 hours.
The results presented in Table IV indicate that the addition of ascorbic acid markedly inhibits the formation of methemoglobin by either cobalt or p-aminophenol.
Formation of Methemoglobin in a Solution of Hemoglobin Crystals Incubated with Cobalt
If the transformation of hemoglobin to methemoglobin by the action of cobalt is due entirely to 1563 the inhibition of the cellular reconversion mechanisms, the exposure of crystalline hemoglobin to cobalt, in the absence of the requisite enzymes and their substrates, should produce no more methemoglobin than exposure to any inert substance. The following experiment was done to test this assumption.
Hemoglobin crystals prepared from 20 ml. of normal defibrinated blood as described above were dissolved in 20 ml. of sterile distilled water, and the solution divided into-two parts. To one part was added 0.5 ml. of 0.85 gm. per cent NaCI and to the other 0.5 ml. of 4 gm. per cent CoG,. Each part was then further divided into 0.5 XI. aliquots, which were placed in 10 x 100 mmn. test tubes and incubated at 370 C. Methemogibin determinations were done at appropriate intervals during 24 hours.
The results of an experiment typical of four are plotted in Figure 2 and show that the addition of cobaltous chloride to the solution of hemoz 70~~~~~~~ĩ !g'"'"" globin gave no significantly greater yield of methemoglobin than did the addition of sodium chloride.
DISCUSSION
In normal erythrocytes, both in the circulation and in vitro, hemoglobin is constantly being oxidized to methemoglobin presumably by the process <A auto-oxidation (26) . The methemoglobin thus formed is constantly being reconverted to hemoglobin, chiefly by an enzymatic process which functions so efficiently that both in vkto and in vitro (26) only small amounts of methemoglobin can be found as long as the necessary glycolytic enzymes and their substrates are present. In addition to this process involving glycolysis, methemoglobin may also be -reduced directly by the action of several agents, such as ascorbic acid, cysteine, glutathione, glyceraldehyde, and BAL (dimercaptopropanol) (26, 30) . Under abnormal circumstances methemoglobin may accumulate in erythrocytes due either to an acceleration of the oxidative process beyond the capacity of the normal reduction mechanisms or to a failure of the reduction mechanisms in the presence of the normal oxidative process. It would appear from the experiments cited above that the formation of methemoglobin in blood exposed to cobaltous chloride may best be explained by the latter mechanism. Comparison of the methemoglobin formation by p-aminophenol with that by cobalt, with respect to both rate of formation and effect of anoxia (Table I and II), strongly implies that cobalt does not produce methemoglobin by the same mechanism as does p-aminophenol, a substance known to oxidize hemoglobin directly. Methylene blue both in vitro and in vivo may, in appropriate concentrations, either accelerate the formation of methemoglobin or catalyze its reduction (26) . The former action presumably explains the moderately enhanced formation of methemoglobin by methylene blue alone in oxygen illustrated in Table II . In the first portion of Table III the opposite effect of methylene blue in inhibiting the oxidizing action of p-aminophenol is clearly shown.
Since the reduction of methemoglobin by methylene blue depends on an intact enzymatic reduction system (27, 28) , the failure of methylene blue to reduce the methemoglobin induced by cobalt illustrated in the second portion of Table III implies an interference by cobalt with this reduction system. That the methemoglobin so formed may be reduced in the presence of cobalt without participation of the enzymatic system is demonstrated by the action of ascorbic acid (Table IV) , an agent known to reduce methemoglobin directly. Finally, when hemoglobin is purified and the enzymatic reduction mechanism is no longer present to be inhibited by cobalt, no appreciably greater amounts of methemoglobin are induced by incubation with cobalt than with an inert substance, such as NaCl (Figure 2) .
The implication that cobalt interferes with this normal enzymatic reduction system in vitro may be of importance in relation to the action of cobalt in stimulating erythropoiesis in vivo. If erythropoietic activity depends on the relative oxygen saturation of the marrow cells, or of some other hypothetical regulatory center, erythropoietic activity will be stimulated by any agent which interferes either with the delivery of oxygen to or with the uptake or utilization of oxygen by the regulatory cells (31) . An agent which blocks intracellular enzymatic reduction systems and so inhibits the utilization of oxygen might thus cause histotoxic anoxia of the regulatory cells and so lead to increased erythropoiesis, even though the supply of oxygen brought to these cells was within normal limits. It would appear from the observations reported above that cobalt does in fact inhibit the enzymatic reduction system concerned with the reconversion of methemoglobin to hemoglobin. The failure to find increased levels of methemoglobin in the blood of patients and experimental animals treated with cobalt makes doubtful a relationship between the inhibition of this particular enzyme system of the adult red cell and the development of cobalt polycythemia. Nevertheless, a similar inhibitory effect by cobalt in other and perhaps more sensitive intracellular enzyme systems of other cells might well eventuate there in histotoxic anoxia and hence in erythropoietic stimulation.
SUMMARY
Normal human blood was incubated at 370 C. for 24 hours in the presence of 0.2 per cent cobaltous chloride. Formation of methemoglobin was observed.
Study of the mechanism of methemoglobin formation under these circumstances suggests that cobalt inhibits the normal intracellular reduction system which maintains hemoglobin in the ferrous state.
Others have shown that administration of co- 
